What are the recommended starting doses and monitoring parameters for benazepril (ACE inhibitor), metolazone (thiazide-like diuretic), and bumetanide (loop diuretic) in a patient with hypertension or heart failure?

Recommended Starting Doses and Monitoring for Benazepril, Metolazone, and Bumetanide

Start benazepril at 2.5 mg daily, bumetanide at 0.5-1 mg once or twice daily, and reserve metolazone at 2.5 mg daily only for severe heart failure refractory to loop diuretics, with frequent electrolyte monitoring every 5-7 days initially.

Benazepril (ACE Inhibitor)

Starting Dose

• Initial dose: 2.5 mg once daily 1
• Target maintenance dose: 10 mg twice daily (based on mortality trials) 1
• Can be titrated up from low starting dose to maintenance doses shown effective in large trials 2

Initiation Protocol

Before starting benazepril, follow this structured approach 3, 1, 3, 1:

1. Review and adjust diuretics: Consider reducing or withholding diuretics for 24 hours before initiation to avoid excessive diuresis
2. Timing: May start in the evening when supine to minimize hypotensive effects, though evidence is limited; if morning dosing, supervise for several hours with blood pressure monitoring
3. Avoid potassium-sparing diuretics during ACE inhibitor initiation
4. Avoid NSAIDs completely

Monitoring Parameters

Check the following at 1-2 weeks after each dose increment, at 3 months, then every 6 months 4, 3, 1, 3, 1:

• Blood pressure
• Serum creatinine
• Serum potassium
• Serum sodium

When to Stop or Refer

• Stop treatment if renal function deteriorates substantially 3, 1, 3, 1
• Refer to specialist if 4:
  • Systolic blood pressure <100 mmHg
  • Serum creatinine >150 µmol/L
  • Serum sodium <135 mmol/L

---

Bumetanide (Loop Diuretic)

Starting Dose

• Initial dose: 0.5-1 mg once or twice daily 4, 5, 6
• Maximum dose: 10 mg daily 4, 5
• Duration of action: 4-6 hours 5

Clinical Context

Loop diuretics like bumetanide are first-line for fluid retention in heart failure and should always be combined with an ACE inhibitor 4, 3, 1, 3, 1, 7. They are recommended for all patients with evidence of congestion to relieve symptoms and prevent worsening heart failure 7.

Dosing Strategy

• Start with low dose and increase until urine output increases and weight decreases by 0.5-1 kg daily 5
• For persistent fluid retention: administer twice daily 4, 3, 1, 3, 1
• Bumetanide has better oral bioavailability than furosemide, which may be advantageous in heart failure 5
• Optimal dose appears to be 0.5 mg twice daily based on quality of life and weight loss data 8

Monitoring

• Daily weights (patients should self-monitor and adjust dose within prescribed range)
• Electrolytes (potassium, magnesium, sodium)
• Renal function
• Blood pressure

Important Caveat

Doses above 0.5 mg twice daily may paradoxically worsen outcomes by decreasing left ventricular function and increasing heart rate and plasma noradrenaline in a dose-dependent manner 8. Avoid excessive diuresis.

---

Metolazone (Thiazide-like Diuretic)

Starting Dose

• Initial dose: 2.5 mg once daily 4, 1, 5, 1, 6, 1, 9
• Maximum dose: 10-20 mg daily 4, 5, 9

Critical Indication

Metolazone is NOT a first-line agent. It should be reserved for severe heart failure with persistent fluid retention despite loop diuretics 4, 3, 1, 3, 1, 7. This is a "drug of last resort" added to loop diuretics 4.

When to Use Metolazone

Add metolazone only when 4, 3, 1, 3, 1, 7:

1. Patient has insufficient response to increased doses of loop diuretics
2. Twice-daily loop diuretic dosing has been tried
3. Patient has severe chronic heart failure with refractory edema
4. GFR <30 mL/min (thiazides ineffective at this level, but metolazone retains efficacy) 4, 3, 1, 3, 1

Intensive Monitoring Required

When metolazone is added, check creatinine and electrolytes frequently 4, 3, 1, 3, 1:

• Every 5-7 days initially until stable
• Monitor for severe hypokalemia (<2.5 mM) and hyponatremia (<125 mM), which occur in ~10% of treatment episodes 10
• Watch for hypomagnesemia

Practical Considerations

• Metolazone produces diuretic response despite low GFR 10
• Absorption may be reduced in heart failure 10
• Low doses (≤5 mg) are effective and relatively safe in contemporary outpatients with refractory heart failure 10
• Recent data suggest chlorothiazide may be superior to metolazone for increasing 24-hour urine output (3826 mL vs 2834 mL, p<0.001) without excess electrolyte derangements 11, though weight changes were similar

---

Sequential Approach Algorithm

For hypertension without heart failure:

1. Start benazepril 2.5 mg daily
2. Titrate to 10 mg twice daily over weeks
3. Add thiazide (NOT metolazone) if blood pressure not controlled 12, 13

For heart failure with fluid retention:

1. Start benazepril 2.5 mg daily + bumetanide 0.5-1 mg once or twice daily 4, 3, 1, 3, 1
2. Titrate benazepril to target dose (10 mg twice daily)
3. If inadequate diuresis: increase bumetanide dose or frequency (up to twice daily)
4. If still inadequate: consider bumetanide 0.5 mg twice daily as optimal dose 8
5. Only if severe refractory edema persists: add metolazone 2.5 mg daily with intensive monitoring 4, 3, 1, 3, 1, 7

For heart failure with GFR <30 mL/min:

• Do NOT use standard thiazides
• Use loop diuretics (bumetanide) as primary diuretic
• Metolazone can be added synergistically if needed 4, 3, 1, 3, 1

---

Key Safety Warnings

Avoid These Combinations

• Do NOT combine potassium-sparing diuretics with ACE inhibitors during initiation (risk of hyperkalemia) 4, 3, 1, 3, 1
• Avoid NSAIDs with ACE inhibitors (reduces efficacy, worsens renal function) 4, 3, 1, 3, 1

Common Pitfalls

• Starting metolazone too early: It should only be used after maximizing loop diuretics
• Inadequate monitoring: Metolazone requires frequent electrolyte checks (every 5-7 days initially)
• Excessive diuresis: Can lead to volume contraction, hypotension, and renal insufficiency 5
• Ignoring hypokalemia: Must be corrected, especially with diuretic therapy 4, 5